Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Av. Bandeirantes, 3900, 14049-900 Ribeirao Preto, SP, Brazil.
Departments of Pediatrics and Pharmacology, University of Alberta, Mazankowski Alberta Heart Institute, 462 Heritage Medical Research Center, T6G 2S2 Edmonton, Canada.
Vascul Pharmacol. 2019 May;116:36-44. doi: 10.1016/j.vph.2018.10.002. Epub 2018 Oct 16.
Hypertension is characterized by maladaptive vascular remodeling and enhanced oxidative stress in the vascular wall. Peroxynitrite may directly activate latent matrix metalloproteinase (MMP)-2 in vascular smooth muscle cells (VSMC) by its S-glutathiolation. MMP-2 may then proteolyze calponin-1 in aortas from hypertensive animals, which stimulates VSMC proliferation and medial hypertrophy. Calponin-1 is an intracellular protein which helps to maintain VSMC in their differentiated (contractile) phenotype. The present study therefore investigated whether aortic MMP-2 activity is increased by oxidative stress in early hypertension and then contributes to hypertrophic arterial remodeling by reducing the levels of calponin-1. Male Wistar rats were submitted to the two kidney, one clip (2 K-1C) model of hypertension or sham surgery and were treated daily with tempol (18 mg/kg/day) or its vehicle (water) by gavage from the third to seventh day post-surgery. Systolic blood pressure (SBP) was daily assessed by tail-cuff plethysmography. After one week, aortas were removed to perform morphological analysis with hematoxylin and eosin staining and to analyze reactive oxygen‑nitrogen species levels by dihydroethidium and immunohistochemistry for nitrotyrosine. MMP-2 activity was analyzed by in situ and gelatin zymography and its S-glutathiolation was analyzed by Western blot for MMP-2 of anti-glutathione immunoprecipitates. Calponin-1 levels were identified in aortas by immunofluorescence. SBP increased by approximately 50 mmHg at the first week in 2 K-1C rats which was unaffected by tempol. However, tempol ameliorated the hypertension-induced increase in arterial media-to-lumen ratio and hypertrophic remodeling. Tempol also decreased hypertension-induced aortic oxidative stress and the enhanced MMP-2 activity. S-glutathiolation may be a potential mechanism by which oxidative stress activates MMP-2 in aortas of 2 K-1C rats. Furthermore, calponin-1 was decreased in aortas from 2 K-1C rats and tempol prevented this. In conclusion, oxidative stress may contribute to the increase in aortic MMP-2 activity, possibly by S-glutathiolation, and this may result in calponin-1 loss and maladaptive vascular remodeling in early hypertension.
高血压的特征是血管壁发生适应性血管重构和氧化应激增强。过氧亚硝酸盐可能通过 S-谷胱甘肽化直接激活血管平滑肌细胞(VSMC)中的潜伏基质金属蛋白酶(MMP)-2。MMP-2 随后可能在高血压动物的主动脉中蛋白水解钙调蛋白-1,从而刺激 VSMC 增殖和中膜肥厚。钙调蛋白-1 是一种细胞内蛋白,有助于维持 VSMC 的分化(收缩)表型。因此,本研究旨在探讨早期高血压时主动脉 MMP-2 活性是否因氧化应激而增加,然后通过降低钙调蛋白-1 的水平促进血管肥厚性重塑。雄性 Wistar 大鼠接受双肾一夹(2K-1C)高血压模型或假手术,并从术后第 3 天到第 7 天每天通过灌胃给予替米沙坦(18mg/kg/天)或其载体(水)。通过尾套测压法每天评估收缩压(SBP)。一周后,取出主动脉进行苏木精和伊红染色的形态学分析,并通过二氢乙啶和免疫组化分析活性氧-氮物种水平,以检测硝基酪氨酸。通过原位和明胶酶谱分析 MMP-2 活性,并通过抗谷胱甘肽免疫沉淀物的 MMP-2 进行 Western blot 分析 MMP-2 的 S-谷胱甘肽化。通过免疫荧光鉴定主动脉中的钙调蛋白-1 水平。2K-1C 大鼠在第 1 周时 SBP 增加约 50mmHg,替米沙坦对此无影响。然而,替米沙坦改善了高血压引起的动脉中膜-腔比和肥厚性重塑的增加。替米沙坦还降低了高血压引起的主动脉氧化应激和增强的 MMP-2 活性。S-谷胱甘肽化可能是氧化应激激活 2K-1C 大鼠主动脉中 MMP-2 的潜在机制。此外,钙调蛋白-1 在 2K-1C 大鼠的主动脉中减少,替米沙坦可预防这种情况。总之,氧化应激可能导致主动脉 MMP-2 活性增加,可能是通过 S-谷胱甘肽化,这可能导致钙调蛋白-1 丢失和早期高血压时的适应性血管重构。